News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,861 Results
Type
Article (15288)
Company Profile (299)
Press Release (270268)
Multimedia
Podcasts (80)
Webinars (11)
Section
Business (80228)
Career Advice (199)
Deals (13389)
Drug Delivery (42)
Drug Development (50822)
Employer Resources (33)
FDA (5883)
Job Trends (5222)
News (145715)
Policy (10127)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (945)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21854)
ALS (124)
Alzheimer's disease (1041)
Antibody-drug conjugate (ADC) (242)
Approvals (6073)
Artificial intelligence (267)
Autoimmune disease (110)
Automation (9)
Bankruptcy (108)
Best Places to Work (4608)
BIOSECURE Act (7)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (344)
Cancer (3144)
Cardiovascular disease (237)
Career advice (177)
Career pathing (8)
CAR-T (217)
CDC (6)
Cell therapy (564)
Cervical cancer (14)
Clinical research (43748)
Collaboration (1154)
Company closure (2)
Compensation (591)
Complete response letters (40)
COVID-19 (1112)
CRISPR (86)
C-suite (551)
Cystic fibrosis (112)
Data (4331)
Denatured (15)
Depression (92)
Diabetes (258)
Diagnostics (1411)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (11)
Drug discovery (189)
Drug pricing (50)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31783)
Editorial (27)
Employer branding (4)
Employer resources (31)
Events (51969)
Executive appointments (622)
FDA (7634)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (985)
Gene editing (182)
Generative AI (22)
Gene therapy (487)
GLP-1 (508)
Government (1160)
Grass and pollen (3)
Guidances (166)
Healthcare (6694)
HIV (19)
Huntington's disease (44)
IgA nephropathy (74)
Immunology and inflammation (193)
Immuno-oncology (39)
Indications (67)
Infectious disease (1217)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (27)
IPO (7370)
IRA (12)
Job creations (875)
Job search strategy (149)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (244)
Leadership (9)
Legal (1410)
Liver cancer (42)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (26)
Management (7)
Manufacturing (383)
MASH (130)
Medical device (2730)
Medtech (2739)
Mergers & acquisitions (6641)
Metabolic disorders (729)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (1965)
Neurotech (1)
NextGen: Class of 2026 (2082)
Non-profit (895)
Now hiring (30)
Obesity (333)
Opinion (129)
Ovarian cancer (132)
Pain (102)
Pancreatic cancer (162)
Parkinson's disease (232)
Partnered (14)
Patents (301)
Patient recruitment (327)
Peanut (43)
People (26752)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15492)
Phase 2 (20324)
Phase 3 (12854)
Pipeline (3252)
Policy (92)
Postmarket research (854)
Preclinical (6552)
Press Release (30)
Prostate cancer (146)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (649)
Real estate (1456)
Recruiting (12)
Regulatory (9930)
Reports (19)
Research institute (989)
Resumes & cover letters (26)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (124)
Series A (183)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (16)
Startups (2011)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (64)
Vaccines (337)
Venture capital (69)
Weight loss (175)
Women's health (26)
Worklife (2)
Date
Last 7 days (345)
Last 30 days (1119)
Last 365 days (17863)
2026 (1657)
2025 (18164)
2024 (20608)
2023 (22474)
2022 (27507)
2021 (28887)
2020 (24222)
2019 (16461)
2018 (11945)
2017 (13898)
2016 (11965)
2015 (14484)
2014 (10504)
2013 (7583)
2012 (7593)
2011 (7698)
2010 (7471)
Location
Africa (159)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18368)
Australia (3128)
California (7101)
Canada (1839)
China (778)
Colorado (246)
Connecticut (253)
Delaware (235)
Europe (39487)
Florida (906)
Georgia (209)
Hawaii (2)
Idaho (18)
Illinois (396)
India (35)
Indiana (163)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (740)
Massachusetts (5586)
Michigan (112)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1650)
New Mexico (14)
New York (1767)
North Carolina (828)
North Dakota (6)
Northern California (3490)
Ohio (177)
Oklahoma (12)
Oregon (24)
Pennsylvania (1279)
Puerto Rico (9)
Rhode Island (25)
South America (221)
South Carolina (9)
Southern California (2811)
Tennessee (40)
Texas (908)
United States (23398)
Utah (96)
Virginia (137)
Washington D.C. (37)
Washington State (594)
West Virginia (1)
Wisconsin (46)
285,861 Results for "tune therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novotech Wins Citeline CRO Partnership of the Year Award for Strategic Collaboration with Tune Therapeutics
May 14, 2025
·
3 min read
Press Releases
Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board
March 4, 2025
·
2 min read
Press Releases
Ashvattha Therapeutics Reports the Ability to Tune Nanomedicines to Image Neuroinflammation in Multiple Sclerosis Patients and Tumor Associated Macrophages in Cancer at SNMMI Annual Meeting
June 23, 2025
·
3 min read
Bio NC
Tune Therapeutics Presents First Data Supporting TUNE-401:a First-in-Class Epigenetic Silencer for Hepatitis B
Tune Therapeutics Presents First Data Supporting TUNE-401: a First-in-Class Epigenetic Silencer for Hepatitis B.
December 6, 2023
·
4 min read
Press Releases
AASLD 2024: Tune Therapeutics Shows Near-Complete HepB Virus Repression with Tune-401 Epigenetic Silencer
November 20, 2024
·
3 min read
Press Releases
Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B
November 14, 2024
·
3 min read
Press Releases
Tune Therapeutics Receives Approval to Initiate Clinical Trial in Hong Kong for HepB Epigenetic Silencer
January 7, 2025
·
2 min read
Bio NC
Tune Therapeutics Reveals Epigenetic Editing Program Targeting Hepatitis B Virus
Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection.
November 13, 2023
·
3 min read
Government
Kennedy Changes Tune on MMR Vaccine as Second Child Dies of Measles
Kennedy, a long-time opponent of vaccines, stated that the MMR vaccine is “the most effective way” to combat the measles outbreak, which has already claimed the lives of two children in the U.S.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs
January 13, 2025
·
3 min read
1 of 28,587
Next
